Trial of Spiritual Care Interventions for Patients With Cancer

This study aims to determine the effects of 2 spiritual care interventions. Spiritual wellness and healthcare service utilization will be measured from a sample of advanced cancer patients recruited from outpatient settings.

Study Overview

Detailed Description

This study is a stratified permuted-block RCT to determine the effects of 2 spiritual care interventions on advanced cancer patients' spiritual wellness (i.e., spiritual well-being and satisfaction of spiritual care needs) and specific forms of healthcare service utilization (i.e., hospice enrollment and ICU admissions) in a sample of advanced cancer patients (N=288) recruited from outpatient settings. Patients will be assigned to "Spiritual Care Intervention #1" (active 1), "Spiritual Care Intervention #2" (active 2), or "Spiritual Care Intervention #3" (control) arm of the trial (overall ratio 1:1:1) using permuted-block randomization within strata defined by geographic location (NYC, Houston Metro Area) and recruitment site (NYC: BMH; Houston Metro Area: UTMB, MDACC). Spiritual care intervention details are being withheld until the trial concludes to protect the scientific integrity of the study. Only 1 of the 2 active interventions will be administered at each site at a given time to avoid within-site cross-contamination between the 2 active intervention arms of the trial.

Study Type

Interventional

Enrollment (Estimated)

288

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • New York
      • New York, New York, United States, 11215
        • Recruiting
        • New York Presbyterian Brooklyn Methodist Hospital
        • Contact:
        • Principal Investigator:
          • Alan B Astrow, M.D.
    • Texas
      • Galveston, Texas, United States, 77555
        • Recruiting
        • The University of Texas Medical Branch, Galveston
        • Contact:
        • Principal Investigator:
          • Mukaila Raji, M.D.
      • Houston, Texas, United States, 77030
        • Recruiting
        • M.D. Anderson Cancer Center
        • Contact:
        • Principal Investigator:
          • David Hui, M.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

  1. Diagnosed with an advanced cancer.
  2. Member of a religious faith community organization.
  3. Fluent in English.

Exclusion Criteria:

  1. Received spiritual care from a healthcare chaplain within the past 2 months.
  2. Too weak or cognitively impaired to engage in study activities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Spiritual Care Intervention #1
This is an experimental condition arm. Intervention details are being withheld until the trial concludes to protect the scientific integrity of the study.
Experimental
Experimental: Spiritual Care Intervention #2
This is also an experimental condition arm. Intervention details are being withheld until the trial concludes to protect the scientific integrity of the study.
Experimental
Active Comparator: Spiritual Care Intervention #3
This is the active comparator condition arm. Intervention details are being withheld until the trial concludes to protect the scientific integrity of the study.
Active Comparator

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patients' spiritual wellness as assessed by measures of spiritual well-being
Time Frame: 2 months
The spiritual well-being outcome measure for this trial is the total score for the 12-item Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being Scale [FACIT-Sp-12], which has a range from 0 to 48. The higher the score, the greater the spiritual well-being.
2 months
Participants' number of hospice enrollments
Time Frame: up to 12 months
Number of hospice enrollments over time, up to 12 months.
up to 12 months
Participants' number of ICU admissions
Time Frame: up to 12 months
Number of ICU admissions over time, up to 12 months.
up to 12 months
Patients' spiritual wellness as assessed by measures of satisfaction of spiritual care needs.
Time Frame: 2 months
The satisfaction of spiritual care needs outcome measure for this trial is a reverse-coded total score for the 13-item Spiritual Needs Assessment for Patients [SNAP], which measures unmet spiritual care needs and has a range from 13 to 52. The higher the reverse-coded score, the greater the satisfaction of spiritual care needs.
2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patients' quality of life
Time Frame: 2 months
The quality-of-life outcome measure for this trial is the total score for the 27-item Functional Assessment of Cancer Therapy - General [FACT-G], which has a range of 0 to 108. The higher the score, the greater the quality of life.
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Paul K Maciejewski, Ph.D., Weill Medical College of Cornell University
  • Principal Investigator: Alan B Astrow, M.D., NYP Brooklyn Methodist Hospital
  • Principal Investigator: Mukaila Raji, M.D., The University of Texas Medical Branch
  • Principal Investigator: David Hui, M.D., M.D. Anderson Cancer Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 24, 2026

Primary Completion (Estimated)

April 1, 2029

Study Completion (Estimated)

June 1, 2029

Study Registration Dates

First Submitted

January 29, 2026

First Submitted That Met QC Criteria

February 9, 2026

First Posted (Actual)

February 13, 2026

Study Record Updates

Last Update Posted (Actual)

June 2, 2026

Last Update Submitted That Met QC Criteria

June 1, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 24-08027855
  • R01NR021159 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Advanced Cancer

Clinical Trials on Spiritual Care Intervention #1

Subscribe